Investor Relations

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2021

Company Overview

Codexis, Inc. (Nasdaq: CDXS) is a leading enzyme engineering company that applies its technology to discover and develop novel, high performance enzymes and novel biotherapeutics. Codexis' proven technology drives improvements such as: reduced energy usage, waste generation and capital requirements; higher yields; higher fidelity diagnostics; and more efficacious therapeutics.

Stock Snapshot

IR Contacts

Headquarters

Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
United States
T: (650) 421-8100
media@codexis.com

Investor Relations

Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
T: 650-421-8106
ir@codexis.com

Transfer Agent

EQ Shareowner Services
1110 Centre Pointe Curve
Suite 101
Mendota Heights, MN 55120-4100
T: 800-468-9716
https://www.shareowneronline.com